OTC ANTIHISTAMINE META-ANALYSIS SHOWS 10%-15% MORE PATIENTS OBTAINED RELIEF
This article was originally published in The Tan Sheet
Executive Summary
OTC ANTIHISTAMINE META-ANALYSIS SHOWS 10%-15% MORE PATIENTS OBTAINED RELIEF from cold symptoms in the drug groups than from placebo, FDA consultant Ralph D'Agostino, PhD, Boston University, reported in a Nov. 15 presentation to FDA's Nonprescription Drugs and Pulmonary-Allergy Drugs Advisory Committees. Reporting on the results of a meta-analysis of antihistamine studies in the common cold, D'Agostino said the data "indicate superiority of the antihistamine over the placebo" with a "10%-15% improvement in the drug group versus the placebo group."